renal TMA in SLE remain unknown. Renal histology is mandatory for the diagnosis and the prognostic Background. Renal thrombotic microangiopathy ( TMA) is an uncommon vascular complication of evaluation of renal vasculopathy in SLE. systemic lupus erythematosus (SLE). Its clinical sympKey words: systemic lupus erythematosus; thrombotic toms and impact on renal survival remain unclear.
Results. All patients presented with renal failure Introduction (creatinine 3.3±2.1 mg/dl ), six had proteinuria (2.5±1.3 g/day) with microscopic haematuria in four During recent years we have gained a better undercases. Six patients had hypertension, which was severe standing of the pathophysiology and have improved in five cases. Renal histology disclosed arterial and/or management of immune glomerulonephritis (GN ) in arteriolar thrombosis with parietal thickening without systemic lupus erythematosus (SLE ). In addition, a angeitis (8 patients), glomerular microthrombi (3 world wide-accepted classification of glomerular lesions patients), and vascular fibrin deposits (5/6 patients).
has been established [1] . However, less attention has In two cases, vascular lesions were associated with been paid to intrarenal vascular complications in SLE. a mesangial or a proliferative glomerulonephritis.
Several types of intrarenal vascular lesions have been Thrombocytopenia was present in four patients with reported in SLE. True renal vasculitis is exceptional haemolytic microangiopathic anaemia in one case.
and is characterized by necrotizing angiitis without Lupus anticoagulant (LA) was detected in five of eight parietal immune deposits. Non-inflammatory necrotizpatients, who also had anticardiolipin antibodies (3/7 ing vasculopathy and 'non-complicated' vascular patients) and/or were positive for VDRL (3/6 patients).
immune deposits, defined by the presence of immunoFour patients with LA experienced arterial thrombosis globulins (Ig) and complement fraction deposits within and/or repeated spontaneous abortions. Treatment the arteriolar and capillary walls, are more frequent. consisted of corticosteroids (8 patients), cytotoxic These two forms, which usually coexist with proliferatdrugs (4 patients), plasma exchanges and/or intravenive and active lupus glomerulonephritis, are linked to ous immunoglobulins (4 patients) and antiplatelet the severity of SLE and probably mediated by the and/or anticoagulant therapy (3 patients). Two deposition or in situ formation of immune complexes patients recovered normal renal function and five had [2, 3] . persistent renal insufficiency. One patient started Recent reports have focused on SLE-associated haemodialysis on admission and died of sepsis 2 intrarenal 'non-immune' and non-inflammatory vasculmonths later.
opathy characterized by arterial and/or arteriolar Conclusions. TMA may be the sole renal complication thrombosis with endothelial thickening, in the absence in SLE and is not usually associated with haemolytic of vascular parietal immune deposits or infiltrating microangiopathic anaemia. In our series renal survival inflammatory cells [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . These pathological characwas influenced by the extent and severity of vascular teristics are identical to the lesions of renal thrombotic lesions. Despite a frequent association with antiphosmicroangiopathy ( TMA). Interestingly, renal TMA in pholipid antibodies, pathophysiological mechanisms of SLE may appear as a clinicopathophysiological entity, not linked with SLE activity and antinuclear antibody tests including kaolin clotting time of platelet-poor plasma, such as anticardiolipin (ACL) antibodies or lupus and dilute Russell's viper venom time. Other laboratory anticoagulant (LA) [7] [8] [9] [11] [12] [13] [14] . These antibodies are analyses were performed by routine established methods.
also involved in the generation of renal TMA in primary antiphospholipid (APL) syndrome [9, 15] , and, therefore, are considered as a main factor for the Results promotion of intrarenal arterial thrombosis in SLE. Because only small series have been described in the Characteristics of SLE literature, the clinical and biological symptoms, as well as the prevalence of APL autoantibodies in renal The study sample consisted of five women and three TMA-associated SLE, still need to be defined. Over a male caucasian patients with a mean age of 25±6 7-year period, we collected eight patients with SLE years (range 19-36). All patients satisfied at least four and renal vasculopathy defined by microvascular of the 1982 ARA criteria (mean 5.2; range 4-7). In thrombotic lesions without vasculitis nor significant two patients (patients 1 and 3), SLE had been respectimmune vascular deposits. The aim of this retrospective ively diagnosed 9 and 3 years previously (Table 1) . study was to correlate clinical features, potential pathophysiological mechanisms and long-term renal out-Characteristics of renal involvement come with renal histopathology.
Renal failure was a constant feature with a mean peak serum creatinine value of 3.3±2.1 mg/dl. Significant patients had fibrin glomerular microthrombi. Parietal and/or luminal fibrin deposits were detected by IF in five of six cases. Scanty vascular immune deposits were Biological studies present in three patients. In two cases, vascular lesions ANA were detected using indirect IF; anti-double-stranded were associated with mesangial (patient 5), and focal DNA (anti-dsDNA) autoantibodies were measured by indir-and segmental (patient 1) proliferative glomeruloect IF using Crithidia luciliae, and/or by Farr assay. Total nephritis ( Table 3) .
Subjects and methods
haemolytic complement and levels of C3 and C4 fractions were measured using standard methods. Titres of ACL
Prevalence of APL autoantibodies and related
antibodies and isotypes were studied by ELISA (Biomedical Diagnostics, France). In two patients, anti-b2 glycoprotein I manifestations (b2-GPI ) antibodies were tested by ELISA, as previously Of the eight patients, five had one or several tests described [18] . The presence of a circulating 'lupus' anticoindicating the presence of APL autoantibodies agulant (LA) was detected by a prolonged activated partial ( Table 4) . LA was evident in 5/8 patients and the thromboplastin time, not corrected after dilution of patient's plasma 151 with normal plasma; and/or other coagulation VDRL test was positive in 3/6 patients. Screening for ACL antibodies was performed in 7/8 patients; three (patient 2) or aortic regurgitation (patient 5). None of the patients developed venous thromboses. patients had significant IgG titres (>20 U GPL). Two of them were further investigated for the presence of
In the patients without LA, cerebral ischaemic stroke in patient 6 was the sole extrarenal thrombotic event. anti-b2-GPI antibodies and one was positive by ELISA. In one case (patient 7), LA was the sole In patient 8 the association of seizures, fever, thrombopenia, haemolytic microangiopathic anaemia, and abnormality.
Among the five patients with LA, three (patients 1, renal failure was characteristic of TTP/HUS. Thrombopenia was present in four patients, two of 3 and 7) experienced peripheral and/or cerebral arterial thrombotic episodes. Two women had a history of whom (patients 2 and 7) also had APL antibodies.
The coexistence of autoimmune haemolytic anaemia repeated spontaneous abortions. Two patients had seizures and, in one case, they were associated with and thrombopenia in three cases (patients 2, 6, 7) suggested the diagnosis of Evans syndrome ( Tables 1  Sneddon's syndrome (patient 3) . Two patients had cardiac valvular thickening, with a moderate mitral and 4).
ous
Three of the five patients with LA received antiplatelet agents, without (patient 3) or with fluindione (patients 1 and 2). Although patients 4 and 5 were treated by corticosteroids alone, the remaining patients received multiple regimens, at least two, and up to six for patient 2.
The follow-up period ranged between 2 and 94 months (mean 50±32). Patient 8, with HUS/TTPassociated SLE, presented with oliguric acute renal failure and died 2 months later from disseminated aspergillus infection. No other patient required haemodialysis. Patients 2 and 6 recovered normal renal function (serum creatinine∏1.0 mg/dl ), without proteinuria or haematuria. Four had persistent mild renal insufficiency (mean serum creatinine 1.6±0.2 mg/dl ), with urine abnormalities in patient 1 (class III GN ) and in patient 3. Renal impairment was more severe in patient 5 (serum creatinine 2.7 mg/dl ), with persistent proteinuria. All but one patient (patient 2) with diffuse vascular lesions on initial kidney biopsy had a ( Table 5 ).
×312).

Discussion
Recent studies have dealt with the pathological features and the role of intrarenal TMA-like vasculopathy in the progression of renal insufficiency in SLE. Renal TMA in SLE appears to be less common than immunecomplex mediated vasculopathies; however, its frequency remains still unknown [2] . In a series of 285 patients with SLE, Banfi et al. [3] reported a 9.5% prevalence of immune complex-associated vasculopathies and a 8.4% prevalence of TMA-like lesions.
Although renal TMA may not be easily distinguished from non-inflammatory necrotizing vasculopathy [2] , all of the lupus patients from our series presented with intrarenal lesions compatible with TMA. Arteriolar and/or arterial thrombosis with intimal thickening was found in all cases. Glomerular involvement was evident in four cases, characterized by glomerular microthrombi and/or capillary thickening. Five patients had ischaemic glomerular lesions, and one had focal cortical necrosis. Fibrin parietal or luminal vascular deposits were observed by IF in five cases. In three [19], and contrasted with the abundant immune deposits of non-inflammatory necrotizing vasculopathy Therapeutic modalities and long-term outcome [2, 3] . None of the patients had a severe form of lupus GN, which often coexists with immune-complexAll patients were treated with oral prednisone (0.5-2 mg/kg/day) for several weeks, preceded in four mediated vasculopathies [2, 3] . Previous reports [4, 7, 8, 10, 12, 14] and our data show that renal TMA cases by three intravenous pulses of 600 mg (patient 8) or 1g of methylprednisolone (patients 1, 3 and 4). may be the sole renal manifestation in SLE.
In the present study we found that clinical and Three patients additionaly received hydroxychloroquine. Four patients were subsequently treated by biological symptoms suggestive of renal TMA were not constant. Significant thrombopenia was absent in cyclophosphamide (patients 1, 3, 6) or azathioprine (patient 2). Plasmapheresis and/or high dose intraven-four cases, and only one patient presented with the 
GN, glomerulonephritis; NA: not available. 
CS, corticosteroids; HC, hydroxychloroquine; CYP, cyclophosphamide; AZA, azathioprine; PEx, plasma exchanges; IVIg, high-dose intravenous immunoglobulins; Prot/Haem, final proteinuria/final haematuria; HD, hemodialysis.
classical symptoms of HUS/TTP. The low prevalence promoting role of APL antibodies in the generation of renal TMA in SLE. LA with or without anticardiolipin of haemolytic microangiopathic anaemia in this series could be due to the fact that patients were selected antibodies was detected in the majority of patients with renal TMA-associated SLE reported by Magill upon renal pathological findings. However, the absence of haemolytic microangiopathic anaemia in SLE [6 ] , Kincaid-Smith [7] , Kleincknecht [8] , D'Agati [9] and Farrugia [11] . Moreover, LA [20] and IgG APL patients with renal TMA has been emphasized in previous studies [9] [10] [11] .
antibodies [21] are significantly associated with intraglomerular microthrombi in SLE patients with lupus Renal failure was constantly observed, with a rapidly progressive onset in three patients, and oliguria in one GN. The role of APL antibodies in the pathophysiology of renal TMA in SLE is further enhanced by case. Interestingly, overt proteinuria was present in the majority of the patients, even in the absence of lupus recent publications which have clearly demonstrated the occurrence of TMA in patients with primary APL GN. Microscopic haematuria was detected in four patients, among whom only one had class III lupus syndrome. The pathological lesions and renal symptoms were similar to those observed in patients with GN. Acute renal failure has been reported in most of the series of renal TMA-associated SLE [4] [5] [6] [7] [8] [10] [11] [12] [13] [14] . SLE and renal TMA [8, 9, 12, 15] .
How APL antibodies lead or contribute to thromMoreover, it has been established that mean serum creatinine is significantly higher in SLE patients with bosis is still unknown, but current opinion suggests that part of the procoagulant effect of APL autoantirenal TMA and lupus GN, compared to SLE patients with lupus GN in the absence of intrarenal vascular bodies is linked to the inhibition of the natural anticoagulant properties of b2-GPI, a plasmatic cofactor involvement [3] . Proteinuria and haematuria are nearly constant in the previous observations of renal TMA which has a high affinity for anionic phospholipids [22] . APL antibodies may also be associated with in SLE [4, 5, [8] [9] [10] [11] [12] [13] [14] , even in the absence of GN. However, Farrugia et al. [11] , and Banfi et al. [3] did the development of antiendothelial cell antibodies (AECA), perhaps due to b2-GPI binding to APLnot find significant differences in the amount of proteinuria in patients with lupus GN, whether renal activated endothelium [23] . To our knowledge, the relationship between anti-b2-GPI antibodies, AECA TMA was present or not. In our series, none of the patients had nephrotic syndrome. When nephrotic and renal TMA in SLE has not been studied.
Nevertheless, APL antibodies may be negative using syndrome is reported it is the consequence of an associated proliferative GN [6 ] . Six patients had high routine tests in SLE patients with renal TMA [5, 12, 13] , as we also observed in three cases, and anti-b2-GPI blood pressure, and accelerated hypertension with grade III retinopathy was a prominent feature in three antibodies were not detected in one among two patients of our series. cases. Some investigators have underlined the high prevalence of hypertension in SLE patients with TMA From the present and previous studies, the efficiency of the different treatment modalities for renal TMA in [3, [7] [8] [9] [10] [11] [12] 14 ] similar to other forms of intrarenal vasculopathy [2, 3] . Interestingly, Banfi et al. [3] have shown SLE is difficult to evaluate. By analogy to the results of Bell et al.
[24], corticosteroids and plasma exchanges an increased frequency of hypertension in SLE patients with renal TMA compared to SLE patients with isol-with fresh frozen plasma replacement should be promptly initiated in SLE patients with HUS/TTP and ated lupus GN. Therefore the diagnosis of renal TMA should be considered in SLE patients with renal failure deterioration of renal function. Although ineffective in our case, this regimen has been successfully used in and severe or accelerated hypertension. Finally, except for the patient with TTP-associated SLE, initial pre-some patients with TTP-associated SLE [5] . Five of our patients had APL antibodies; four of these sentation of our patients was suggestive of lupus GN, although glomerular lesions were present in only two suffered from extrarenal thrombotic complications.
Corticosteroids and/or cytotoxic drugs did not influcases. These data confirm that renal histology plays a key role in the diagnosis of the various renal complica-ence LA and ACL antibodies, which may persist for years in SLE patients beyond disappearance of other tions of SLE.
It is noteworthy that TMA-related renal symptoms autoantibodies and clinical symptoms of active disease [25, 26 ] . A recent report has clearly demonstrated that led to the diagnosis of SLE in six of eight patients. This unusual mode of presentation of the disease has long-term and high-intensity warfarin therapy is required to prevent the recurrence of thrombosis in been rarely reported [5, 10, 12, 14] . At the time of the diagnosis of renal TMA, most of our cases exhibited these patients [27] . In our series, none of the two LA-positive patients treated by fluindione experienced clinical and biological signs of active SLE. However, as previously reported, in three of our patients renal further thrombotic complications. Except in the patient with initial anuria, renal insufficiency improved or TMA was observed in quiescent SLE [7] .
In SLE patients the coexistence of renal TMA and remained stable. Considering the severity of hypertension in SLE patients with renal TMA, optimal control antiphospholipid antibodies has emerged in most of the recent studies reported in the literature, and was of blood pressure should be obtained to prevent the progression of renal failure. Despite the small number evident in five patients of our study. Four patients had a history of repeated spontaneous abortions and/or of patients in this series, it appears that renal prognosis was also influenced by the severity and the extent of arterial thromboses and fulfilled the criteria for APL syndrome [17] . These findings are in favour of the renal arteriolar lesions. As renal TMA in SLE has systemic lupus erythematosus and the antiphospholipid synbeen shown to have deleterious effects on long-term drome. Am J Kidney Dis 1992; 20: [150] [151] [152] [153] [154] [155] [156] [157] [158] renal function [3, 5, 7, 8, 10, 13, 14] and overall survival 13. Jain R, Chartash E, Susin M, Furie R. Systemic lupus eryth- [4,7,8,10- 
